Used in research and development for immunomodulatory therapies, particularly in autoimmune diseases such as multiple sclerosis and inflammatory bowel disease. It targets the CD3 complex on T cells to modulate immune response without causing significant T cell depletion. Investigated for its potential to induce immune tolerance, making it a candidate for treating chronic inflammatory conditions. Also explored in preclinical studies for neurodegenerative diseases due to its anti-inflammatory effects in the central nervous system. Administered via non-systemic routes, such as intranasal delivery, to enhance brain targeting and reduce peripheral side effects.